How much does a box of Enasidenib currently cost?

Enasidenib is a targeted drug used to treat acute myeloid leukemia (AML). Currently, the original version of this drug has not yet been officially launched in China, so it is not covered by medical insurance in the domestic market. Due to the lack of official channels, patients who need to use ensidipine usually need to purchase it through formal overseas channels, which makes the acquisition and cost of the drug a difficult problem for many patients.

In overseas markets, the price of ensidipine is relatively high. Taking the common specifications of 50mg30 tablets and 100mg30 tablets as examples, each box is usually sold for about 300,000 yuan. The specific price will fluctuate due to exchange rate changes and supply conditions. This high price makes it unaffordable for many patients in the long term, especially for chronic conditions that require ongoing treatment.

In order to reduce the financial burden on patients, generic versions of ensidipine have also appeared on the market. For example, the price of a box of 50mg*30 tablets of generic drugs produced by Lucius Pharmaceutical Factory in Laos is about more than 1,000 yuan. Although the price gap is obvious, the active ingredients of these generic drugs are basically the same as those of the original drugs, which can provide patients with effective treatment options and become an important medication route for many patients with limited economic conditions.

In general, ensidipine is an important AML targeted treatment drug. The original drug is relatively expensive and has not yet entered the domestic market, while generic drugs provide patients with a more affordable alternative. Patients should consult a professional doctor before use and choose appropriate drugs and purchase channels based on their own condition and financial status to ensure the continuity and effectiveness of treatment.

Reference materials:https://www.idhifa.com/